Sumitomo Mitsui DS Asset Management Company Ltd Has $274,000 Stock Holdings in Align Technology, Inc. $ALGN

Posted by Brenda Bartman on May 11th, 2026

Sumitomo Mitsui DS Asset Management Company Ltd lessened its stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 76.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,755 shares of the medical equipment provider’s stock after selling 5,835 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Align Technology were worth $274,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Comerica Bank grew its holdings in Align Technology by 0.6% during the fourth quarter. Comerica Bank now owns 13,656 shares of the medical equipment provider’s stock valued at $2,132,000 after purchasing an additional 76 shares during the last quarter. Arizona State Retirement System grew its holdings in Align Technology by 0.4% during the third quarter. Arizona State Retirement System now owns 20,387 shares of the medical equipment provider’s stock valued at $2,553,000 after purchasing an additional 79 shares during the last quarter. Sentry Investment Management LLC boosted its position in shares of Align Technology by 73.1% in the third quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 79 shares during the period. Independence Bank of Kentucky boosted its position in shares of Align Technology by 77.7% in the fourth quarter. Independence Bank of Kentucky now owns 183 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 80 shares during the period. Finally, Allworth Financial LP boosted its position in shares of Align Technology by 3.3% in the third quarter. Allworth Financial LP now owns 2,874 shares of the medical equipment provider’s stock valued at $360,000 after acquiring an additional 92 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Jefferies Financial Group increased their price objective on Align Technology from $155.00 to $185.00 and gave the company a “hold” rating in a research report on Thursday, February 5th. Wells Fargo & Company increased their price objective on Align Technology from $181.00 to $200.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Piper Sandler increased their price objective on Align Technology from $220.00 to $235.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Mizuho increased their price objective on Align Technology from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Finally, Stifel Nicolaus increased their price objective on Align Technology from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $205.85.

View Our Latest Stock Analysis on ALGN

Insider Buying and Selling

In related news, EVP John Morici sold 7,969 shares of the firm’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $189.31, for a total value of $1,508,611.39. Following the completion of the transaction, the executive vice president directly owned 8,237 shares of the company’s stock, valued at $1,559,346.47. This trade represents a 49.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.75% of the stock is currently owned by company insiders.

Align Technology Stock Performance

ALGN opened at $168.78 on Monday. The stock has a market capitalization of $12.09 billion, a price-to-earnings ratio of 28.32, a P/E/G ratio of 1.74 and a beta of 1.70. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $208.30. The business has a 50 day moving average of $178.11 and a 200-day moving average of $165.34.

Align Technology (NASDAQ:ALGN – Get Free Report) last issued its earnings results on Wednesday, April 29th. The medical equipment provider reported $2.58 EPS for the quarter, topping the consensus estimate of $2.26 by $0.32. The firm had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.Align Technology’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period last year, the business earned $2.13 earnings per share. Equities analysts predict that Align Technology, Inc. will post 9.43 EPS for the current year.

Align Technology declared that its Board of Directors has approved a stock repurchase program on Wednesday, April 29th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to purchase up to 1.6% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its shares are undervalued.

Align Technology Company Profile

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.